title: The future of generic HIV drugs in Rhode Island.
abstract: The number of HIV-infected persons in the United States continues to increase and most patients with HIV will be on antiretroviral therapy (ART) for many decades. The introduction of generic antiretroviral medications has the potential for significant cost savings which may then be accompanied by improved access. State AIDS Drug Assistance Programs will be made more effective by the switch to generic ARTs. Cost savings and barriers to the introduction of generic ART are discussed.
authors.affiliation: Medical Student at the Warren Alpert Medical School at Brown University.
authors.forename: Jennifer Y
authors.initials: JY
authors.lastname: Lee
authors.forename: Rebecca
authors.initials: R
authors.lastname: Reece
authors.forename: Brian
authors.initials: B
authors.lastname: Montague
authors.forename: Aadia
authors.initials: A
authors.lastname: Rana
authors.forename: Nicole
authors.initials: N
authors.lastname: Alexander-Scott
authors.forename: Timothy
authors.initials: T
authors.lastname: Flanigan
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D017046:Cost Savings; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics; D006801:Humans; D012237:Rhode Island
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic
keywords: HIV/AIDS; Rhode Island; antiretrovirals; generic drugs